findmyKOL

Scott Macdiarmid, MD

Enriched profile

Director, Bladder Control and Pelvic Pain Center, Alliance Urology Specialists · Alliance Urology Specialists

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Greensboro, NC · Southeast · United StatesSpecialtyUrologyFocusGenitourinary
Active KOLfindmyKOL type: EliteLatest publication2018Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Scott Macdiarmid is Director, Bladder Control and Pelvic Pain Center, Alliance Urology Specialists at Alliance Urology Specialists. ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 13 Oct 2026

Scott A. MacDiarmid, MD, is Director, Bladder Control and Pelvic Pain Center, Alliance Urology Specialists. The public record shows 159 publications with 4,549 citations (h-index 32), centered on Genitourinary. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 35 companies.

  • Top research focus: Genitourinary
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 35 companies

Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Urinary Incontinence2 trialsUrinary Incontinence, Urge2 trialsUrinary Bladder, Overactive1 trial

Research focus

OpenAlex concept fingerprint
Genitourinary

Drugs & molecules

across trials, industry payments and publications
Gemtesageneric · VibegronClinical trials—Industry payments157Publications—Nocdurnageneric · DesmopressinClinical trials—Industry payments26Publications—Keytrudageneric · PembrolizumabClinical trials—Industry payments23Publications—Xtandigeneric · EnzalutamideClinical trials—Industry payments21Publications—Myrbetriqgeneric · MirabegronClinical trials—Industry payments20Publications—Orgovyxgeneric · RelugolixClinical trials—Industry payments16Publications—Nubeqageneric · DarolutamideClinical trials—Industry payments14Publications—Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments13Publications—Aveedgeneric · TestosteroneClinical trials—Industry payments10Publications—Lynparzageneric · OlaparibClinical trials—Industry payments10Publications—Erleadageneric · ApalutamideClinical trials—Industry payments8Publications—NirmatrelvirClinical trials—Industry payments7Publications—

Works with

trial sponsors and companies reporting payments
Valencia Technologies CorporationClinical trials2Industry payments141Urovant Sciences IncClinical trials—Industry payments87Sumitomo Pharma America, Inc.Clinical trials—Industry payments76Astellas Pharma US IncClinical trials—Industry payments29Antares Pharma, Inc.Clinical trials—Industry payments27Medtronic, Inc.Clinical trials—Industry payments26Merck Sharp & Dohme LLCClinical trials—Industry payments23Laborie Medical Technologies Corp.Clinical trials—Industry payments21Abbvie Inc.Clinical trials—Industry payments15Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments14Janssen Biotech, Inc.Clinical trials—Industry payments14Pfizer Inc.Clinical trials—Industry payments14E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments5Endo Pharmaceuticals Inc.Clinical trials—Industry payments5Novartis Pharmaceuticals CorporationClinical trials—Industry payments5Urogen Pharma, Inc.Clinical trials—Industry payments4Allergan, Inc.Clinical trials—Industry payments2AstraZeneca Pharmaceuticals LPClinical trials—Industry payments2Caldera Medical, IncClinical trials—Industry payments2Coloplast CorpClinical trials—Industry payments2Dendreon Pharmaceuticals LLCClinical trials—Industry payments2Ferring Pharmaceuticals Inc.Clinical trials—Industry payments2Supernus Pharmaceuticals, Inc.Clinical trials—Industry payments2Verity Pharmaceuticals Inc.Clinical trials—Industry payments2Amgen Inc.Clinical trials—Industry payments1Blue Earth Diagnostics LimitedClinical trials—Industry payments1Boston Scientific CorporationClinical trials—Industry payments1EMKinetics, IncClinical trials1Industry payments—Immunitybio, Inc.Clinical trials—Industry payments1Myovant Sciences Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
35companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 13 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Oct 2026

35 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 79 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 0 publications: search, sort and filter.Explore →

Background & recognition

Updated 13 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Fellow

    Royal College of Physicians and Surgeons of Canada (FRCPSC)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.